Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE stock price ended at $0.070261 on 月曜日, after dropping 4.78%
On Feb 09, 2026 00:00, the price of HIVE fell by 4.78%, dropping from $0.076583 to $0.070261 with 24h trading volume reaching $2.4M HIVE.
